Treatment of Dysphagia in Parkinson's Disease: A Systematic Review

International Journal of Environmental Research and Public Health
Remedios López-LiriaPatricia Rocamora-Pérez

Abstract

The incidence of oropharyngeal dysphagia in Parkinson's disease (PD) is very high. It is necessary to search for effective therapies that could prevent pneumonia. Previous results should be interpreted cautiously as there is a lack of evidence to support the use of compensatory or rehabilitative approaches to dysphagia. We reviewed the scientific literature to describe the treatments of dysphagia in PD. A systematic review was performed in PubMed, Scopus, Elsevier, and Medline according to PRISMA standards in 2018. The articles that did not mention dysphagia secondary to PD or used surgical treatment were excluded. Eleven articles met the criteria with information from 402 patients. The review relates to different protocols, such as training in expiratory muscle strength, postural techniques, oral motor exercises, video-assisted swallowing therapy, surface electrical stimulation, thermal stimulation, touch, compensatory interventions, training regime for swallowing, neuromuscular electrical stimulation, Lee Silverman voice treatment, swallow maneuver, airway protection, and postural compensation maneuvers. This review identifies the rationing interventions in each trial, if they are efficient and equitable. Several rehabilitati...Continue Reading

References

Mar 26, 1998·Dysphagia·S E LangmoreW J Loesche
Sep 30, 1999·Controlled Clinical Trials·H D ClarkA Laupacis
Jan 11, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·A El SharkawiC Werner
Mar 1, 2006·Clinical Rehabilitation·Ying Jiang, Kathleen E Norman
Jun 10, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Kenichi SatoUNKNOWN Juntendo Parkinson Study Group
Apr 21, 2007·Current Treatment Options in Neurology·Marian L Evatt
Oct 18, 2008·Clinics·Valter Nilton FelixRenato José Soares
Apr 29, 2009·Parkinsonism & Related Disorders·Cristina TassorelliEmilia Martignoni
Jul 22, 2009·PLoS Medicine·David MoherUNKNOWN PRISMA Group
Mar 18, 2010·Brain Research·John A RussellTimothy Schallert
Jun 3, 2011·European Journal of Epidemiology·Karin WirdefeldtJack Mandel
Jul 14, 2012·International Journal of Language & Communication Disorders·Sarah K SmithHeulwen Sheldrick
Sep 8, 2012·Clinical Interventions in Aging·Livia SuraMichael A Crary
Nov 8, 2012·Parkinsonism & Related Disorders·Yael ManorJacob T Cohen
Apr 19, 2013·The Laryngoscope·Laura W J BaijensChristel Desjardins-Rombouts
May 4, 2013·Parkinsonism & Related Disorders·Asako YoritakaNobutaka Hattori
Jul 23, 2013·NeuroRehabilitation·Natalie ArgoloAna Caline Nóbrega
May 6, 2014·Parkinsonism & Related Disorders·M R A van HoorenB Kremer
Oct 22, 2014·World Journal of Methodology·Paolo BorrioneAttilio Parisi
Dec 17, 2014·The International Journal of Neuroscience·Xiao-Hong Ba
Nov 19, 2015·Folia Phoniatrica Et Logopaedica : Official Organ of the International Association of Logopedics and Phoniatrics (IALP)·Camila Dalbosco GadenzMauriceia Cassol
Nov 2, 2016·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Philippe RizekMandar S Jog
Feb 6, 2017·Journal of Neural Transmission·Ole-Bjørn Tysnes, Anette Storstein

❮ Previous
Next ❯

Software Mentioned

Avidemux
Digital Swallowing Workstation

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.